Efficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLD
Status:
Not yet recruiting
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
Currently researches are focusing on the effect of antioxidants in the treatment of
non-alcoholic fatty liver disease (NAFLD). Since N-acetyl cysteine (NAC) has been proven to
have antioxidant and anti-inflammatory properties, therefore, we will conduct this study to
determine the effect of NAC in patients of NAFLD with raised liver enzymes.